Montag & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $26.4M | Buy |
28,752
+543
| +2% | +$550K | 1.23% | 14 |
|
|
2025
Q4 | $30.3M | Buy |
28,209
+5,906
| +26% | +$5.65M | 1.38% | 10 |
|
|
2025
Q3 | $17M | Sell |
22,303
-335
| -1% | -$249K | 0.78% | 30 |
|
|
2025
Q2 | $17.6M | Sell |
22,638
-284
| -1% | -$221K | 0.86% | 26 |
|
|
2025
Q1 | $18.9M | Sell |
22,922
-573
| -2% | -$477K | 0.95% | 24 |
|
|
2024
Q4 | $18.1M | Sell |
23,495
-5,119
| -18% | -$4.24M | 0.86% | 27 |
|
|
2024
Q3 | $25.4M | Buy |
28,614
+1,263
| +5% | +$1.14M | 1.2% | 13 |
|
|
2024
Q2 | $24.8M | Sell |
27,351
-415
| -1% | -$332K | 1.25% | 13 |
|
|
2024
Q1 | $21.6M | Sell |
27,766
-1,245
| -4% | -$886K | 1.08% | 18 |
|
|
2023
Q4 | $16.9M | Sell |
29,011
-847
| -3% | -$494K | 0.94% | 25 |
|
|
2023
Q3 | $16M | Sell |
29,858
-586
| -2% | -$302K | 1.01% | 20 |
|
|
2023
Q2 | $14.3M | Sell |
30,444
-3,887
| -11% | -$1.63M | 0.88% | 25 |
|
|
2023
Q1 | $11.8M | Sell |
34,331
-4,138
| -11% | -$1.4M | 0.77% | 27 |
|
|
2022
Q4 | $14.1M | Sell |
38,469
-1,497
| -4% | -$531K | 0.94% | 21 |
|
|
2022
Q3 | $12.9M | Sell |
39,966
-850
| -2% | -$269K | 0.89% | 20 |
|
|
2022
Q2 | $13.2M | Sell |
40,816
-463
| -1% | -$139K | 0.86% | 25 |
|
|
2022
Q1 | $11.8M | Sell |
41,279
-202
| -0.5% | -$52K | 0.63% | 36 |
|
|
2021
Q4 | $11.5M | Buy |
41,481
+14,320
| +53% | +$3.63M | 0.57% | 43 |
|
|
2021
Q3 | $6.28M | Sell |
27,161
-404
| -1% | -$99.7K | 0.34% | 81 |
|
|
2021
Q2 | $6.33M | Sell |
27,565
-1,425
| -5% | -$286K | 0.34% | 84 |
|
|
2021
Q1 | $5.42M | Buy |
28,990
+33
| +0.1% | +$6.46K | 0.31% | 91 |
|
|
2020
Q4 | $4.89M | Sell |
28,957
-11
| -0% | -$1.64K | 0.3% | 89 |
|
|
2020
Q3 | $4.29M | Sell |
28,968
-200
| -0.7% | -$31K | 0.35% | 79 |
|
|
2020
Q2 | $4.79M | Sell |
29,168
-100
| -0.3% | -$15.3K | 0.42% | 68 |
|
|
2020
Q1 | $4.06M | Sell |
29,268
-5,303
| -15% | -$729K | 0.41% | 70 |
|
|
2019
Q4 | $4.54M | Sell |
34,571
-1,500
| -4% | -$174K | 0.36% | 73 |
|
|
2019
Q3 | $4.03M | Sell |
36,071
-1,482
| -4% | -$165K | 0.35% | 74 |
|
|
2019
Q2 | $4.16M | Sell |
37,553
-24,355
| -39% | -$2.87M | 0.37% | 68 |
|
|
2019
Q1 | $8.03M | Sell |
61,908
-30,010
| -33% | -$3.65M | 0.74% | 35 |
|
|
2018
Q4 | $10.6M | Sell |
91,918
-1,778
| -2% | -$199K | 1.14% | 19 |
|
|
2018
Q3 | $10.1M | Buy |
93,696
+55,180
| +143% | +$5.52M | 0.88% | 27 |
|
|
2018
Q2 | $3.29M | Sell |
38,516
-275
| -0.7% | -$22.6K | 0.34% | 83 |
|
|
2018
Q1 | $3M | Sell |
38,791
-1,726
| -4% | -$139K | 0.31% | 91 |
|
|
2017
Q4 | $3.42M | Sell |
40,517
-1,649
| -4% | -$140K | 0.33% | 91 |
|
|
2017
Q3 | $3.61M | Sell |
42,166
-1,534
| -4% | -$126K | 0.39% | 75 |
|
|
2017
Q2 | $3.6M | Sell |
43,700
-6,485
| -13% | -$529K | 0.4% | 67 |
|
|
2017
Q1 | $4.22M | Sell |
50,185
-1,275
| -2% | -$102K | 0.47% | 61 |
|
|
2016
Q4 | $3.79M | Buy |
51,460
+250
| +0.5% | +$18.6K | 0.45% | 70 |
|
|
2016
Q3 | $4.11M | Buy |
51,210
+450
| +0.9% | +$36K | 0.52% | 63 |
|
|
2016
Q2 | $4M | Sell |
50,760
-300
| -0.6% | -$22.6K | 0.53% | 64 |
|
|
2016
Q1 | $3.68M | Buy |
51,060
+1,525
| +3% | +$115K | 0.52% | 62 |
|
|
2015
Q4 | $4.17M | Buy |
49,535
+1,335
| +3% | +$111K | 0.61% | 52 |
|
|
2015
Q3 | $4.03M | Sell |
48,200
-1,000
| -2% | -$84.4K | 0.63% | 53 |
|
|
2015
Q2 | $4.11M | Sell |
49,200
-12,346
| -20% | -$941K | 0.6% | 56 |
|
|
2015
Q1 | $4.47M | Buy |
61,546
+900
| +1% | +$64.1K | 0.65% | 50 |
|
|
2014
Q4 | $4.18M | Buy |
60,646
+3,061
| +5% | +$207K | 0.63% | 53 |
|
|
2014
Q3 | $3.73M | Buy |
57,585
+1,715
| +3% | +$109K | 0.62% | 54 |
|
|
2014
Q2 | $3.47M | Buy |
55,870
+50,940
| +1,033% | +$3.04M | 0.57% | 59 |
|
|
2014
Q1 | $290K | Buy |
+4,930
| New | +$275K | 0.05% | 196 |
|
|
2013
Q4 | – | Sell |
-27,050
| Closed | -$1.36M | – | 232 |
|
|
2013
Q3 | $1.36M | Hold |
27,050
| – | – | 0.25% | 108 |
|
|
2013
Q2 | $1.33M | Buy |
+27,050
| New | +$1.47M | 0.27% | 104 |
|
Other funds holding LLY
VCM
VPM
Montag & Associates's LLY Position: Q1 2026 in Review
Montag & Associates increased its Eli Lilly (LLY) stake by 1.9% in Q1 2026, buying an estimated $550K and bringing the position to 28,752 shares worth $26.4M. The position accounts for 1.23% of the portfolio, ranked #14.
Montag & Associates first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. The position peaked at $30.3M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Montag & Associates held 28,752 shares of Eli Lilly worth $26.4M as of Q1 2026.
- Montag & Associates bought 543 Eli Lilly shares in Q1 2026, an estimated $550K.
- Eli Lilly made up 1.23% of Montag & Associates's portfolio in Q1 2026, its #14 holding.
- Montag & Associates first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
- Montag & Associates's Eli Lilly position peaked at $30.3M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.